The findings from immune infiltration analyses and multiple immune cell analyses provided evidence that PLAC8 participates in modulating the immune microenvironment of ccRCC and consequently influences the efficacy of immunotherapy. The gene discussed is PLAC8; the disease is nonpapillary renal cell carcinoma.